|
Vincent Milano joined the company in 1996 and has served as vice president chief financial officer and treasurer of ViroPharma since 1997. Mr. Milano has been instrumental in building ViroPharma including leading efforts in raising $630 million in capital and the acquisition of Vancocin(R) from Eli Lilly and Company. He has played a critical role in all business development and investor relations activities of the company and has contributed significantly to establishing the strategic direction of the company. Prior to joining ViroPharma he was with KPMG LLP independent certified public accountants where he served as senior manager. Mr. Milano received his bachelor of science degree in accounting from Rider College. He is a director of Verticalnet Inc.
| 